Mr. Krishnan is a Process Development Scientist by background and has a decade of experience in vaccine, monoclonal antibodies and viral vector modalities from pre-clinical to late stage process characterization, validation and commercialization activities such as BLA authoring. He is passionate about providing solutions to bring treatments to market. As a BioChemical engineer from South India, he holds a Master’s degree in Biotechnology from the Pennsylvania State University. Ratish has managed process development teams at leading companies such as Novartis and Pfizer prior to his current role in 2019 where he serves as a technical consultant and initiates strategic collaborations and partnerships in gene therapy, both internally and externally. He has presented scientific lectures at conferences, webinars and has made key contributions in peer-reviewed journals, articles and white papers.